Announcements Trials
Browse Landscape

Phase

Phase 2 69Phase 1 41Phase 1/2 26Phase 3 7Phase EARLY_PHASE1 6Phase NA 5Phase 4 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 2Oligodendroglioma 1Glioma 1Brain Neoplasms 1Astrocytoma 1

Interventions

trametinib 2dabrafenib 2perampanel 1olutasidenib 1Valproic Acid 1Temozolomide 1Restraint, Physical 1Outcome Assessment, Health Care 1Observational Studies as Topic 1Levetiracetam 1Cytochrome P-450 CYP3A 1Cytochrome P-450 CYP2C9 1Cytochrome P-450 CYP2C8 1Cytochrome P-450 CYP2C19 1Cytochrome P-450 CYP2B6 1Cytochrome P-450 CYP1A2 1Anticonvulsants 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Glioma × Temozolomide × Clear all
NCT06625047 2026-04-29

Comparing Telehealth and In-person Assessments in Glioma Patients Receiving Oral Chemotherapy

Mayo Clinic

Phase 4 Completed
30 enrolled
CNS

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡